Skip to main content
. 2014 Dec 2;47(4):790–795. doi: 10.4143/crt.2014.126

Fig. 1.

Fig. 1.

Kaplan-Meier estimate of progression-free survival (PFS) from the start of regorafenib therapy. CI, confidence interval.